CXCR5 and COVID-19: Similarly, CM CD8+ T cells in COVID-19 convalescents also contained a higher level of CXCR5-expressing cells as compared with control group (6.07% (4.29; 8.76) vs. 3.22% (1.88; 4.67), p < 0.001).